We are international
Donate
• about myeloma TEXT SIZE   

The IMF is pleased to bring you CITINGS - Novel Therapies, now published monthly, featuring the most up-to-date information on research advances and new therapies for the treatment for multiple myeloma. CITINGS - Novel Therapies provides physicians and other health care professionals with references and Internet links to the most current U.S. and international journal articles, abstracts, and white papers. Each issue presents articles related to new drugs, either as the focus of the study or as part of the discussion of myeloma treatment.

CITINGS - Novel Therapies
previous     next      view all

Special ASH Edition: Serum Free Light Chain Assays – ASH 2009 Issue

Volume VI, Issue III, Q3/2009: Thalidomide and Revlimid® Issue

Volume VI, Issue III, Q3/2009: VELCADE® (bortezomib) Issue

ASCO Special Edition, Q2/2009: Thalidomide and Revlimid® Issue

ASCO Special Edition, Q2/2009: VELCADE® (bortezomib) Issue

Special Edition ASCO 2009: Serum Free Light Chain Assays Issue

Volume VI, Issue I, Q1/2009: Thalidomide and Revlimid® Issue

Volume VI, Issue I, Q1/2009: VELCADE® (bortezomib) Issue

Volume V, Issue IV, ASH 2008 Special Edition: Thalidomide and Revlimid® Issue

Volume V, Issue IV, ASH 2008 Special Edition: VELCADE® (bortezomib) Issue

previous     next      view all